Reimplantation of EndoBarrier device proves safe in obesity trial

04/30/2012 | (Boston)

GI Dynamics' EndoBarrier gastrointestinal sleeve can be reimplanted in obese patients who have previously been treated with the device without complications, according to a 19-patient study. The findings were presented at the 5th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders in Barcelona, Spain.

View Full Article in: (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC